Parkinson Disease: all 4,583 studies

Page 13 of 46. Open to participants first (1,097), then studies with results posted, then the rest; newest registration first within each.

• Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's DiseaseCompletedNCT04380142Phase 3Results posted
• Study Assessing Efficacy and Safety of AKST4290 in Subjects With Parkinson's Disease on Stable Dopaminergic TreatmentCompletedNCT04369430Phase 2Results posted
• A Study of TAK-071 in People With Parkinson DiseaseCompletedNCT04334317Phase 2Results posted
• In-home Cycling for Individuals With PD: FeasibilityCompletedNCT04300023Not applicableResults posted
• Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease PsychosisCompletedNCT04292223Phase 4Results posted
• Light Therapy for PD - Dose SelectionCompletedNCT04291014Not applicableResults posted
• Speech, Linguistic and Acoustic Markers in Parkinson's DiseaseCompletedNCT04273672Results posted
• Intranasal Insulin in Parkinson's DiseaseCompletedNCT04251585Phase 2Results posted
• Sing for Your SaunterCompletedNCT04246476Not applicableResults posted
• Flexible-Dose Trial in Early Parkinson's Disease (PD)CompletedNCT04223193Phase 3Results posted
• Fixed-Dose Trial in Early Parkinson's Disease (PD)CompletedNCT04201093Phase 3Results posted
• A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese PatientsCompletedNCT04193527Phase 3Results posted
• Study of CVN424 in Parkinson's Disease Patients With Motor FluctuationsCompletedNCT04191577Phase 2Results posted
• Computational Modeling of 60 Hz Subthalamic Nucleus Deep Brain Stimulation for Gait Disorder in Parkinson's DiseaseCompletedNCT04184791Not applicableResults posted
• Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose QuetiapineTerminatedNCT04164758Phase 2Results posted
• taVNS in Mild to Moderate Parkinson's DiseaseCompletedNCT04157621Not applicableResults posted
• Smartphone-based Wearable TelerehabilitationCompletedNCT04146454Results posted
• Advancing Understanding of Transportation OptionsCompletedNCT04141891Not applicableResults posted
• Effects of Exercise on Glymphatic Functioning and Neurobehavioral Correlates in Parkinson's DiseaseCompletedNCT04140708Not applicableResults posted
• Monitoring Anti-Dementia Drugs by Serum LevelsCompletedNCT04117178Phase 4Results posted
• Dental Appliance for Parkinson's DiseaseCompletedNCT04082663Not applicableResults posted
• Study of UB-312 in Healthy Participants and Parkinson's Disease PatientsCompletedNCT04075318Phase 1Results posted
• Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase InhibitorsCompletedNCT04064294Results posted
• Feasibility and Effect of a Strategy-Based Cognitive Intervention for Parkinson DiseaseCompletedNCT04048122Not applicableResults posted
• Cerebellar Transcranial Direct Current Stimulation in Parkinson's DiseaseCompletedNCT04046055Not applicableResults posted
• Bilateral Closed Loop Deep Brain Stimulation for Freezing of Gait Using Neural and Kinematic FeedbackCompletedNCT04043403Not applicableResults posted
• Treatment of REM Sleep Behavior Disorder (RBD) With Sodium OxybateCompletedNCT04006925Phase 4Results posted
• Pragmatic Cyclical Lower Extremity Exercise Trial for Parkinson's DiseaseCompletedNCT04000360Not applicableResults posted
• Mindfulness Based Stress Reduction for Parkinson's Disease: A Longitudinal StudyCompletedNCT03998462Not applicableResults posted
• Utilization of Target Ranges to Treat Parkinson's Disease With the PKGTerminatedNCT03984305Not applicableResults posted
• Parkinson's Disease: Enhancing Physical Therapy With Brain Stimulation for Treating Postural Instability.Active, not recruitingNCT03981055Not applicableResults posted
• Highly Challenging Balance Program to Reduce Fall Rate in PDCompletedNCT03972969Not applicableResults posted
• Clinical Trial to Evaluate the Safety and Tolerability of Hydrogen in Patients With Parkinson's DiseaseTerminatedNCT03971617Phase 2/3Results posted
• Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)CompletedNCT03944785Results posted
• A Study to Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's DiseaseTerminatedNCT03922711Phase 2Results posted
• A Pilot Study of Terazosin for Parkinson's DiseaseCompletedNCT03905811Phase 1/2Results posted
• Parkinson's Disease Inpatient Clinical Knowledge and ManagementTerminatedNCT03888287Not applicableResults posted
• A Post-Market Study Evaluating the Safety of Infinity DBS System With MR Conditional LabelingCompletedNCT03884231Results posted
• Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's DiseaseCompletedNCT03883217Not applicableResults posted
• Kick Out Parkinson's Disease 2CompletedNCT03882879Not applicableResults posted
• A Study to Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of LevodopaCompletedNCT03881371Phase 3Results posted
• Open Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease (PD) Participants With Motor FluctuationsCompletedNCT03877510Phase 3Results posted
• Evaluation of Using Vibrotactile Coordinated Reset for Management of Parkinson's DiseaseTerminatedNCT03857867Not applicableResults posted
• Multi-chip Meta-analysis of Parkinson's Disease for Clinical Validation of Small Samples of Key Genes in DiseaseCompletedNCT03848455Results posted
• Effect of Safinamide on Parkinson's Disease Related Chronic PainCompletedNCT03841604Phase 4Results posted
• Cognitive Rehab for Parkinson'sCompletedNCT03836963Not applicableResults posted
• Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic FailureTerminatedNCT03829657Phase 3Results posted
• 31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Parkinson's DiseaseCompletedNCT03815916Phase 2Results posted
• Physiology, Imaging and Modeling of Essential TremorCompletedNCT03811405Not applicableResults posted
• Low Dose Niacin (Vitamin B3) for Parkinson's DiseaseTerminatedNCT03808961Not applicableResults posted
• Aerobic Exercise in Parkinson's DiseaseCompletedNCT03808675Not applicableResults posted
• Stimulation Parameters and Non-motor Symptoms in PD Treated With DBSTerminatedNCT03800108Not applicableResults posted
• Vibration Impact on Parkinson's TremorCompletedNCT03799614Not applicableResults posted
• Evaluation of the Infinity Deep Brain Stimulation Electrode Screening Mode ToolCompletedNCT03794661Not applicableResults posted
• Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)CompletedNCT03781791Phase 2Results posted
• A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD)CompletedNCT03781167Phase 3Results posted
• Nabilone for Non-motor Symptoms in Parkinson's DiseaseCompletedNCT03773796Phase 3Results posted
• Nabilone for Non-motor Symptoms in Parkinson's DiseaseCompletedNCT03769896Phase 2Results posted
• Robotic Walking Device to Improve Mobility in Parkinson's DiseaseCompletedNCT03751371Not applicableResults posted
• Rasagiline Tablets Special Drug Use-Results Survey "Survey on Long-term Safety"CompletedNCT03727139Results posted
• A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive ImpairmentCompletedNCT03713957Phase 2Results posted
• The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180)TerminatedNCT03702816Phase 2Results posted
• Voice Treatment for Parkinson's DiseaseCompletedNCT03700684Not applicableResults posted
• Feasibility and Acceptability of a Physical Activity Behavior Change Intervention for Parkinson's DiseaseCompletedNCT03696589Phase 1/2Results posted
• Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and ControlsCompletedNCT03675282Phase 1/2Results posted
• A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor FluctuationsCompletedNCT03670953Phase 3Results posted
• PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706TerminatedNCT03655236Phase 2Results posted
• Atomoxetine for Freezing of Gait in Parkinson's DiseaseCompletedNCT03651856Phase 3Results posted
• Amyloidopathy, Cholinopathy, Dopamine Responsiveness and Freezing of Gait in PDCompletedNCT03647137Results posted
• Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime SleepinessCompletedNCT03624920Phase 2Results posted
• Effect of Mental Imagery Training on Brain Plasticity and Motor Function in Individuals With Parkinson's DiseaseCompletedNCT03623386Not applicableResults posted
• BTRX-246040 Study in Participants With Parkinson's Disease With Motor FluctuationsCompletedNCT03608371Phase 2Results posted
• Genetic Influences on Response to Gait Rehabilitation in Parkinson's DiseaseCompletedNCT03607695Not applicableResults posted
• Advancing Pre-operative Targeting for Deep Brain Stimulation in the Globus Pallidus InternusTerminatedNCT03600740Not applicableResults posted
• A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's DiseaseCompletedNCT03582137Phase 2Results posted
• Kick Out Parkinson's Disease- Karate InterventionCompletedNCT03555695Not applicableResults posted
• In-Home Care for Patients With PSP and Related DisordersCompletedNCT03552484Not applicableResults posted
• Innovations in Dementia Empowerment and ActionCompletedNCT03550131Not applicableResults posted
• Mild Cognitive Impairment and Endurance Exercise in Parkinson's DiseaseCompletedNCT03542474Not applicableResults posted
• Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off ReversalCompletedNCT03541356Phase 2Results posted
• Convection Enhanced Delivery of CSF in DBS for Parkinson'sCompletedNCT03540134Not applicableResults posted
• Assessing Tele-Health Outcomes in Multiyear Extensions of PD TrialsCompletedNCT03538262Results posted
• The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-DopaCompletedNCT03521635Phase 4Results posted
• Walking and mHealth to Increase Participation in Parkinson DiseaseCompletedNCT03517371Not applicableResults posted
• Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and DepressionCompletedNCT03482882Phase 2Results posted
• GPR109A and Parkinson's Disease: Role of Niacin in Outcome MeasuresCompletedNCT03462680Not applicableResults posted
• Modulation of GABA-A Receptors in Parkinson Disease-Flumazenil ArmCompletedNCT03462641Phase 1/2Results posted
• Asymmetric Subthalamic Deep Brain Stimulation for Axial Motor Dysfunction in Parkinson's DiseaseCompletedNCT03462082Not applicableResults posted
• Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil ArmCompletedNCT03440112Phase 1/2Results posted
• Unlocking Dystonia From Parkinson's Disease With Directional DBS TechnologyCompletedNCT03409120Not applicableResults posted
• A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)CompletedNCT03391882Phase 3Results posted
• Videofluoroscopic Swallowing Study (VFSS)TerminatedNCT03387267Not applicableResults posted
• Efficacy and Tolerability of IRL790 in Parkinson's Disease DyskinesiaCompletedNCT03368170Phase 2Results posted
• COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal GelCompletedNCT03362879Results posted
• Biomarkers to Guide Directional DBS for Parkinson's DiseaseCompletedNCT03353688Not applicableResults posted
• Cognitive Rehabilitation for PDCompletedNCT03335150Not applicableResults posted
• A Phase 3 Study With P2B001 in Subjects With Early Parkinson'sCompletedNCT03329508Phase 3Results posted
• Airway Protective Mechanisms in PD (R01)CompletedNCT03321019Results posted
• Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's DiseaseTerminatedNCT03318523Phase 2Results posted
• A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)CompletedNCT03305809Phase 2Results posted

← Parkinson Disease overview